ARK Investment Management (Cathie Wood) — RXRX Trade History
Quarter-by-quarter changes in the Recursion Pharmaceuticals Inc position · CUSIP 75629V104
Currently held · 5.3 YearsFirst seen: 2021 Q2
| Quarter | Filed | Activity | Shares | Δ Shares | Δ % | Value | % Port. |
|---|---|---|---|---|---|---|---|
| 2026 Q2 | 2026-08-14 | Add | 41,337,632 | 1,124,863 | +2.8% | $151.7M | 0.98% |
| 2026 Q1 | 2026-05-12 | Add | 40,212,769 | 2,895,913 | +7.8% | $123.5M | 0.96% |
| 2025 Q4 | 2026-02-11 | Add | 37,316,856 | 3,771,357 | +11.2% | $152.6M | 1.01% |
| 2025 Q3 | 2025-11-12 | Add | 33,545,499 | 556,868 | +1.7% | $163.7M | 0.97% |
| 2025 Q2 | 2025-07-30 | Reduce | 32,988,631 | -1,826,871 | -5.2% | $166.9M | 1.22% |
| 2025 Q1 | 2025-05-07 | Add | 34,815,502 | 2,469,104 | +7.6% | $184.2M | 1.84% |
| 2024 Q4 | 2025-02-04 | Reduce | 32,346,398 | -422,788 | -1.3% | $218.7M | 1.82% |
| 2024 Q3 | 2024-10-31 | Add | 32,769,186 | 4,626,268 | +16.4% | $215.9M | 1.98% |
| 2024 Q2 | 2024-07-26 | Add | 28,142,918 | 3,555,357 | +14.5% | $211.1M | 1.87% |
| 2024 Q1 | 2024-04-18 | Add | 24,587,561 | 3,933,274 | +19.0% | $245.1M | 1.70% |
| 2023 Q4 | 2024-01-17 | Add | 20,654,287 | 13,777,689 | +200.4% | $203.7M | 1.21% |
| 2023 Q3 | 2023-10-18 | Add | 6,876,598 | 2,138,081 | +45.1% | $52.6M | 0.40% |
| 2023 Q2 | 2023-07-10 | Add | 4,738,517 | 1,161,655 | +32.5% | $35.4M | 0.23% |
| 2023 Q1 | 2023-04-17 | Add | 3,576,862 | 477,372 | +15.4% | $23.9M | 0.16% |
| 2022 Q4 | 2023-01-24 | Reduce | 3,099,490 | -260,321 | -7.7% | $23.9M | 0.21% |
| 2022 Q3 | 2022-10-17 | Add | 3,359,811 | 627,724 | +23.0% | $35.7M | 0.25% |
| 2022 Q2 | 2022-07-11 | Reduce | 2,732,087 | -95,076 | -3.4% | $16.7M | 0.10% |
| 2022 Q1 | 2022-04-19 | Add | 2,827,163 | 595,150 | +26.7% | $20.2M | 0.08% |
| 2021 Q4 | 2022-01-28 | Reduce | 2,232,013 | -361,823 | -13.9% | $38.2M | 0.12% |
| 2021 Q3 | 2021-11-12 | Add | 2,593,836 | 215,161 | +9.0% | $59.7M | 0.14% |
| 2021 Q2 | 2021-08-05 | New | 2,378,675 | 2,378,675 | — | $86.8M | 0.16% |
| 2021 Q1 | 2021-05-13 | — | — | — | — | — | — |
| 2020 Q4 | 2021-02-12 | — | — | — | — | — | — |
| 2020 Q3 | 2020-10-30 | — | — | — | — | — | — |
| 2020 Q2 | 2020-08-11 | — | — | — | — | — | — |
| 2020 Q1 | 2020-05-14 | — | — | — | — | — | — |
| 2019 Q4 | 2020-01-31 | — | — | — | — | — | — |
| 2019 Q3 | 2019-11-12 | — | — | — | — | — | — |
| 2019 Q2 | 2019-07-30 | — | — | — | — | — | — |
| 2019 Q1 | 2019-05-13 | — | — | — | — | — | — |
| 2018 Q4 | 2019-02-11 | — | — | — | — | — | — |
| 2018 Q3 | 2018-11-07 | — | — | — | — | — | — |
| 2018 Q2 | 2018-08-07 | — | — | — | — | — | — |
| 2018 Q1 | 2018-05-14 | — | — | — | — | — | — |
| 2017 Q4 | 2018-02-12 | — | — | — | — | — | — |
| 2017 Q3 | 2017-11-09 | — | — | — | — | — | — |
| 2017 Q2 | 2017-08-11 | — | — | — | — | — | — |
| 2017 Q1 | 2017-05-15 | — | — | — | — | — | — |
| 2016 Q4 | 2017-02-13 | — | — | — | — | — | — |
Share counts are split-adjusted. Time held counts consecutive quarters ending with the latest filing; more than ten years shows as ">10 Years".
13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.